Background In mouse models of atherosclerosis, knockout of the PLA2G2A gene has been shown to reduce the volume of atherosclerotic plaques. Clinical trials have demonstrated the potential of using the sPLA2 inhibitor Varespladib in combination with ...
Xin Wang +9 more
doaj +1 more source
The venom of the Russell's viper (Daboia siamensis) contains neurotoxic and myotoxic phospholipase A2 toxins which can cause irreversible damage to motor nerve terminals.
Wayne C. Hodgson (412268) +3 more
core
Targeting Key Enzymatic Snake Venom Proteins Using Repurposed Small Molecule Inhibitors: Emerging Adjuncts to Antivenom Therapy. [PDF]
Reghu N +8 more
europepmc +1 more source
Why does local edema persist? Immunological mismatch between phospholipase A2 potency and antivenom affinity in Protobothrops mucrosquamatus envenomation. [PDF]
Ho CH +6 more
europepmc +1 more source
<i>Bothrops</i> venom variation drives niche-specific pharmacology through Ca<sup>2+</sup> signalling and membrane damage. [PDF]
Bourke LA +5 more
europepmc +1 more source
Role of Regulated Cell Death Pathways in Snakebite Envenomation: Mechanisms, Crosstalk, and Therapeutic Opportunities. [PDF]
Alangode A +8 more
europepmc +1 more source
Ruthenium Compounds Differentially Inhibit Group IA and IIA Snake Venom Phospholipase A<sub>2</sub> Anticoagulant Activity. [PDF]
Nielsen VG, Nielsen SA.
europepmc +1 more source
Anti-inflammatory therapies to prevent cardiovascular events: systematic review and network meta-analysis of randomised controlled trials. [PDF]
Boczar KE +10 more
europepmc +1 more source
Large animal models for the assessment of snakebite envenoming therapies. [PDF]
Benard-Valle M +7 more
europepmc +1 more source
Reshaping antivenom therapy: A triple-synergy strategy featuring broadly neutralizing antibodies and a small-molecule PLA<sub>2</sub> inhibitor. [PDF]
Zhou Y, Shi N, Gao X, Luo L.
europepmc +1 more source

